Gradual Prednisone Tapering in Lupus Patients

Introduction to Tapering

• Gradual tapering of prednisone is recommended for patients with lupus who have been in clinical remission for at least 12 months, with complete discontinuation possible after achieving sustained remission for ≥12 months, as recommended by the guideline society, based on evidence from Kidney International 1

Evaluation Before Tapering

• Before attempting prednisone withdrawal, evaluate disease activity status, confirming clinical remission for at least 12 months, as suggested by Kidney International 1
• Patients with serologically active clinically quiescent (SACQ) disease have higher flare risk after withdrawal, according to Annals of the Rheumatic Diseases 2

Tapering Schedule

• From 5 mg/day, reduce prednisone by 1 mg every 4-8 weeks, as recommended by Kidney International 1

Risk of Flare

• Higher risk of flare is associated with serologically active clinically quiescent disease, as reported by Annals of the Rheumatic Diseases 2
• Attempting withdrawal before achieving sustained remission increases failure risk, as noted by Kidney International 1

Monitoring and Follow-up

• Schedule more frequent follow-up visits during the tapering period and monitor for signs of disease activity at each visit
• The guideline society recommends continuing hydroxychloroquine during and after prednisone withdrawal to reduce flare risk, although the specific citation for this is ignored

Common Mistakes to Avoid

• Ignoring serological activity, such as positive anti-dsDNA or low complement despite clinical remission, increases flare risk, as warned by Annals of the Rheumatic Diseases 2
• Withdrawing prednisone too early, before achieving sustained remission, increases failure risk, as cautioned by Kidney International 1